Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
about
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell deathCalmodulin binding to the Fas death domain. Regulation by Fas activationA novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domainThe HECT-type E3 ubiquitin ligase AIP2 inhibits activation-induced T-cell death by catalyzing EGR2 ubiquitinationCaspases: the executioners of apoptosisMCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosisMolecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptorFas-ligand: privilege and perilAdvances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International WorkshopHow I treat autoimmune lymphoproliferative syndromeApoptosis: a mechanism of cell killing by influenza A and B virusesMolecules, morphology, and ecology indicate a recent, amphibious ancestry for echidnasIdentification of amino acid residues important for ligand binding to FasDeath by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal ToxinThe scarless heart and the MRL mouseCTLA-4 ligation blocks CD28-dependent T cell activationFas involvement in Ca(2+)-independent T cell-mediated cytotoxicityMultiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseasesFADD adaptor in cancerThe mouse anterior chamber angle and trabecular meshwork develop without cell deathSLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosusThe cancer stem cell: evidence for its origin as an injured autoreactive T cellFollicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft RejectionRole of Tumor Necrosis Factor Superfamily in Neuroinflammation and AutoimmunityTransplantation tolerance and its outcome during infections and inflammationSomatic mutagenesis in autoimmunityDeath receptor-ligand systems in cancer, cell death, and inflammationThe role of CD95 and CD95 ligand in cancerNew allogeneic hematopoietic stem cell transplantation method: hematopoietic stem cell transplantation plus thymus transplantation for intractable diseasesAntitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cellsViral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathwaysRIPK-dependent necrosis and its regulation by caspases: a mystery in five actsInterleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10Mouse model of lymph node metastasis via afferent lymphatic vessels for development of imaging modalitiesModelling clinical systemic lupus erythematosus: similarities, differences and success storiesFas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative diseaseInitiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139
P2860
Q24293504-3C8F3FAE-E5D8-438E-8333-FE4D33CBCBEFQ24299040-DF705204-35DB-430E-B631-69270F1C1D38Q24306835-C0BA22CF-52FE-4101-B999-52F5FAB5E348Q24320362-7194EDFC-826F-490A-B9F1-4FF85E375EC7Q24530218-5EFBF582-FCCF-40A9-8A4F-562B5D65ED27Q24563123-56F561EB-547D-444C-93F7-38C358DACF18Q24564319-0804C25B-2767-45AD-8E99-3BE4FF141D36Q24568305-76E9E87A-939C-49FF-97BC-FEED20F9AD82Q24597543-727C3FD4-98E9-4F5B-954C-7FCC53E5EFCEQ24612227-84B27348-05AC-48A2-80E2-ABEC02195CA1Q24623371-7EE17843-EA12-403E-8155-8D84893AA6E6Q24632569-C6E85E3E-1482-40AE-8F00-6C0E462EFB8AQ24633207-AFF5B350-FE90-4858-9B41-02E0BBD2F4C3Q24646086-E5A5DF80-DEF9-4DB7-919F-BBE0DF86865FQ24653740-2BE7A3B7-F7D3-40C0-8612-98A8131453C9Q24669797-1C128729-C8E4-45A2-8B32-22ACA5C302D8Q24673297-6ADE382E-298C-42DD-ADD5-8F9D8EE62E22Q24675305-DCDFEECD-4B86-495B-9A0E-A0DA5B430374Q24678229-2C0B6F99-2C35-4D45-AD18-AFF8A9DA7BB1Q24680778-30D13B09-7523-4C76-929B-C60CE46CD499Q24793730-3F9F0D21-8A0E-4C81-B1F1-09EB5A20921FQ24795895-4890ADF3-CF7B-4E23-A2B0-815A750A9559Q24797197-271E24CA-1D5F-4D3C-A859-7AD7BBF496E5Q24804939-3C528BF4-CFDD-48FF-9879-E2345BA2AC82Q25256839-3B712731-EC62-4F70-AF1A-0AA802BDA8C9Q26738329-C549AEA5-40D9-413C-B2E1-B3E514748A2FQ26800155-58069C4C-41E7-477A-A170-24D10C1F52A0Q26829817-7312CEBD-047B-4B6A-9280-8BC7B695ED48Q26860815-C5B18505-1AAA-4A38-BBD0-DB61FD6CCDA5Q26865568-C7E528EE-B40D-4BDE-89EC-43FB8073FE39Q26995847-CA048B51-8895-4DE3-8695-68175AFF0B0AQ26996496-5B99995A-8704-45A8-860A-89065FA5BFA3Q27003110-994B414D-FA9C-4F25-B390-2CB7E0E27CEAQ27010127-3D3A9B1A-B069-4330-928D-94900C5AB08EQ27026600-5B06F8C5-EBF0-4FB5-AB8D-80D8EB601CCFQ27310464-917BD6F0-CB24-4B39-8B5E-1A9C5D69FEF1Q27316237-987CB78C-541B-4D98-B5B0-18D8A6E08B1EQ28074217-595DFFAD-6A91-4661-B5DD-4AAA3A83DDDBQ28115268-2D866E37-9788-4010-BA50-C856DB8859F2Q28139691-067FEDC6-35E4-4A7F-BE2C-CCD4FBFD40CD
P2860
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Lymphoproliferation disorder i ...... ntigen that mediates apoptosis
@ast
Lymphoproliferation disorder i ...... ntigen that mediates apoptosis
@en
type
label
Lymphoproliferation disorder i ...... ntigen that mediates apoptosis
@ast
Lymphoproliferation disorder i ...... ntigen that mediates apoptosis
@en
prefLabel
Lymphoproliferation disorder i ...... ntigen that mediates apoptosis
@ast
Lymphoproliferation disorder i ...... ntigen that mediates apoptosis
@en
P2093
P3181
P356
P1433
P1476
Lymphoproliferation disorder i ...... ntigen that mediates apoptosis
@en
P2093
Brannan CI
Copeland NG
Jenkins NA
Watanabe-Fukunaga R
P2888
P3181
P356
10.1038/356314A0
P407
P577
1992-03-26T00:00:00Z
P6179
1041635124